TrialDrug design, development and therapy2022

Cyclosporine A (0.05%) Ophthalmic Gel in the Treatment of Dry Eye Disease: A Multicenter, Randomized, Double-Masked, Phase III, COSMO Trial.

Wenyan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.